13 High Growth Penny Stocks That Are Profitable
In this article, we will take a look at the 13 high growth penny stocks that are profitable.
Xtant Medical Holdings Inc. (XTNT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 73,114,592 | $49,425,464 | 0.89% | |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 11,394,000 | $7,435,724 | +219% | 0.37% |
| 3. | Altium Capital Jacob Gottlieb | 7,415,413 | $5,012,819 | 1.47% | |
| 4. | Juniper Investment Company Alexis Michas And John Bartholdson | 1,318,944 | $891,606 | 0.37% | |
| 5. | Renaissance Technologies Jim Simons | 694,208 | $469,285 | -2% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.20 | 41,670 | Officer | 815,860 | 2023-11-17 | Filing | |
| $0.48 | 2,264,861 | Director | 5,850,716 | 2022-10-07 | Filing | |
| $7.20 | 342,132 | Large Shareholder, Director | 3,316,128 | 2018-02-14 | Filing | |
| $7.20 | 603,687 | Large Shareholder, Director | 5,890,884 | 2018-02-14 | Filing | |
| $7.20 | 342,132 | Large Shareholder, Director | 3,316,128 | 2018-02-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.61 | 8,673 | Officer | 403,960 | 2023-01-18 | Filing | |
| $0.62 | 51,100 | Officer, Director | 1,506,584 | 2022-10-19 | Filing | |
| $0.68 | 80,000 | Officer, Director | 1,557,684 | 2022-10-18 | Filing | |
| $0.48 | 4,300 | Officer | 703,571 | 2022-08-17 | Filing | |
| $0.49 | 18,700 | Officer | 707,871 | 2022-08-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,499,993 | $1,694,992 | 0% | |
| 2. | 594,029 | $671,253 | 0.6% | |
| 3. | 468,680 | $529,608 | 0.06% | |
| 4. | 368,500 | $416,405 | 0% | |
| 5. | 261,905 | $296,080 | 0% |
News See All
Is XTNT Stock A Buy Here?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
Is Xtant Medical Holdings, Inc. (XTNT) A Good Stock To Buy?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Hedge Funds Watching Xtant Medical Holdings, Inc. (XTNT) From Afar
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Hedge Funds Watching Xtant Medical Holdings, Inc. (XTNT) From Afar
A whopping number of 13F filings filed with U.S.